Cheryl H. Arrowsmith, Ph.D., chief scientist, Structural Genomics Consortium; senior scientist, Ontario Cancer Institute / Princess Margaret Cancer Centre; professor, department of medical biophysics, University of Toronto
Stephen Frye, Ph.D., Fred Eshelman Distinguished Professor, Center for Integrative Chemical Biology and Drug Discovery; co-program leader, Lineberger Comprehensive Cancer Center , The University of North Carolina at Chapel Hill
Cheryl H. Arrowsmith, Ph.D., chief scientist, Structural Genomics Consortium; senior scientist, Ontario Cancer Institute / Princess Margaret Cancer Centre; professor, department of medical biophysics, University of Toronto
Stephen Frye, Ph.D., Fred Eshelman Distinguished Professor, Center for Integrative Chemical Biology and Drug Discovery; co-program leader, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill
Deirdre Cooper Owens, Ph.D., director, Humanities in Medicine Program and Charles and Linda Wilson Professor in the History of Medicine, University of Nebraska-Lincoln
A rich program of lectures and seminars featuring internal and external speakers help Rockefeller scientists keep abreast of their colleagues’ work and forge fruitful interdisciplinary collaborations.
According to a new study from Joel Cohen, statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences. #Rockefellerscience... See MoreSee Less
An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens. #SeekMagazine... See MoreSee Less
Drug-resistant strains of tuberculosis bacteria affect half a million people a year. Research from the Darst lab shows that a compound first discovered in the 1980s may be able to help. #Rockefellerscience... See MoreSee Less
Research from Sohail Tavazoie providing the first evidence that our own genetics can promote metastasis is competing in #STATMadness—a tournament to find the best innovations in science and medicine.
Vote now to help Rockefeller move to the next round! ... See MoreSee Less
In 1926, exactly 95 years ago today, Rockefeller's Clara J. Lynch demonstrated that cancer is heritable. Although the first cancer-causing gene would not be discovered until almost half a century later, Lynch noticed that certain laboratory mice developed cancer spontaneously. She performed a series of experiments, cross-breeding cancer prone mice and tracing how subsequent lineages appeared to inherit lung and breast cancer from their predecessors. Her conclusions pioneered the young field of cancer genetics, laying the groundwork for the now universal study of oncogenes and tumor suppressor genes. Through her mouse experiments Lynch also eventually bred a unique strain of Swiss albino mice, which she shared with the broader scientific community. The descendants of Lynch's mice would become mainstays of biology research around the world. www.ncbi.nlm.nih.gov/pmc/articles/PMC2131108/... See MoreSee Less
Excited to share an article about my submission to the Dance Your Ph.D Contest. Thanks to members of the @InLiuOfBulkExps and @RockefellerUniv for their participation! https://t.co/pbGKMo1bKI @LaurelOld
According to a new study from Joel Cohen, statistical modeling may one day help scientists anticipate and manage a wide range of extreme occurrences. #RockefellerScience
https://t.co/DaJuRCRkNN
An elaborate set of zebrafish experiments is shining light on one of neuroscience’s greatest enigmas: How brains make decisions. By tracking neural activity, scientists can now predict a fish’s next move before it happens. #SeekMagazine https://t.co/o6gZmkdwJs
Drug-resistant strains of tuberculosis bacteria affect half a million people a year. Research from the #DarstLab shows that a compound first discovered in the 1980s may be able to help. #RockefellerScience
https://t.co/pb2lEcOaEV
